Price$37.60+0.55 (+1.47%)
01:30 PM07:45 PM
News · 26 weeks54+50%
2026-03-012026-08-23
Mix2090d
- Insider10(50%)
- SEC Filings5(25%)
- Other3(15%)
- Earnings2(10%)
Latest news
25 items- INSIDERDirector Schmidt David exercised 20,000 shares at a strike of $5.00 and returned $771,800 worth of shares to the company (20,000 units at $38.59) (SEC Form 4)4 - Astrana Health, Inc. (0001083446) (Issuer)
- INSIDERNew insider Vong John claimed ownership of 22,426 shares (SEC Form 3)3 - Astrana Health, Inc. (0001083446) (Issuer)
- INSIDERFormer Officer Sobotka Glenn returned 11,793 shares to the company, decreasing direct ownership by 84% to 2,246 units (SEC Form 4)4 - Astrana Health, Inc. (0001083446) (Issuer)
- SECSEC Form 10-Q filed by Astrana Health Inc.10-Q - Astrana Health, Inc. (0001083446) (Filer)
- SECAstrana Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Astrana Health, Inc. (0001083446) (Filer)
- PRAstrana Health, Inc. Reports Second Quarter 2026 ResultsCompany to Host Conference Call on Thursday, August 6, 2026, at 2:30 p.m. PT/5:30 p.m. ETReports revenue of $972.5 million, up 49% year-over-year, net income of $18.5 million, up 81% year-over-year, and adjusted EBITDA (1) of $68.9 million, up 43% year-over-year for the three months ended June 30, 2026Reports net cash provided by operating activities of $100.8 million and free cash flow (2) of $92.9 million for the six months ended June 30, 2026ALHAMBRA, Calif., Aug. 6, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers t
- PRAstrana Health, Inc. Schedules 2026 Second Quarter Financial Results Release and Conference CallALHAMBRA, Calif., July 14, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the second quarter ended June 30, 2026, after the close of the stock market on Thursday, August 6, 2026. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day. Participant Dial-in Numbers: 877-858-9810 / +1 201-
- PRAstrana Health Strengthens Leadership Team to Accelerate Long-Term GrowthNames Daniel Rothman President of Physician Enterprise and Vishal Gupta Senior Vice President of Enterprise TransformationALHAMBRA, Calif., July 13, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced the appointments of Daniel Rothman as President of Physician Enterprise and Vishal Gupta as Senior Vice President of Enterprise Transformation. These additions further deepen Astran
- SECAstrana Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Astrana Health, Inc. (0001083446) (Filer)
- PRAstrana Health ACOs Deliver $120.4 Million in Gross Shared Savings in 2024 Performance YearAll Eight ACOs Achieve Net Shared SavingsALHAMBRA, Calif., July 13, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that its Accountable Care Organizations (ACOs) generated $120.4 million in gross shared savings during the 2024 performance year. All eight of Astrana's affiliated ACOs generated shared savings, including five participating in the Medicare Shared Savings Program
- SECAstrana Health Inc. filed SEC Form 8-K: Leadership Update8-K - Astrana Health, Inc. (0001083446) (Filer)
- INSIDERCEO and President Sim Brandon covered exercise/tax liability with 1,093 shares, decreasing direct ownership by 0.09% to 1,245,292 units (SEC Form 4) (for tax liability)4 - Astrana Health, Inc. (0001083446) (Issuer)
- INSIDERDirector Schmidt David was granted 4,525 shares, increasing direct ownership by 14% to 36,019 units (SEC Form 4)4 - Astrana Health, Inc. (0001083446) (Issuer)
- INSIDERDirector Mazdyasni Matthew was granted 4,525 shares, increasing direct ownership by 13% to 39,288 units (SEC Form 4)4 - Astrana Health, Inc. (0001083446) (Issuer)
- INSIDERDirector Kitayama Mitchell W was granted 4,991 shares, increasing direct ownership by 18% to 32,837 units (SEC Form 4)4 - Astrana Health, Inc. (0001083446) (Issuer)
- INSIDERDirector Dong Linda was granted 4,525 shares, increasing direct ownership by 5% to 97,133 units (SEC Form 4)4 - Astrana Health, Inc. (0001083446) (Issuer)
- INSIDERDirector Dai, Weili was granted 4,525 shares, increasing direct ownership by 33% to 18,188 units (SEC Form 4)4 - Astrana Health, Inc. (0001083446) (Issuer)
- INSIDERDirector Chiang John was granted 4,525 shares, increasing direct ownership by 15% to 35,373 units (SEC Form 4)4 - Astrana Health, Inc. (0001083446) (Issuer)
- SECAstrana Health Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Astrana Health, Inc. (0001083446) (Filer)
- PRAstrana Health Named to the 2026 Fortune 1000 List Following Strong Revenue GrowthALHAMBRA, Calif., June 4, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced it has been named to the Fortune 1000® for 2026, marking its debut on the annual ranking of the largest U.S. companies by revenue. The recognition reflects Astrana's continued growth and momentum as it builds AI-powered healthcare infrastructure that helps providers deliver more accessible, coordinated, and affordable care.
- ANALYSTAstrana Health upgraded by Barclays with a new price targetBarclays upgraded Astrana Health from Equal Weight to Overweight and set a new price target of $50.00
- INSIDERCOO and CFO Basho Chandan covered exercise/tax liability with 8,155 shares, decreasing direct ownership by 5% to 159,610 units (SEC Form 4) (tax withholding)4 - Astrana Health, Inc. (0001083446) (Issuer)
- PRAstrana Health, Inc. Announces Appointment of Interim National Medical DirectorALHAMBRA, Calif., May 12, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced the appointment of George Christides, M.D. as Interim National Medical Director. In this role, Dr. Christides will lead the Company's population health, care management, and care navigation initiatives across its national platform.Dr. Christides is an ac
- SECAstrana Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Astrana Health, Inc. (0001083446) (Filer)
- SECAstrana Health Inc. filed SEC Form 8-K: Leadership Update8-K - Astrana Health, Inc. (0001083446) (Filer)
ASTH FAQ
5 questionsWhere does ASTH stock trade?
Astrana Health Inc. (ASTH) is listed on NASDAQ.What sector and industry is ASTH in?
Astrana Health Inc. operates in the Consumer Discretionary sector, Professional Services industry.What are analysts saying about ASTH?
Astrana Health Inc. has had 7 recent analyst actions on file. The most recent action was from Barclays: Overweight on 2026-05-26. Recent price targets range from $2800.00 to $3600.00.What companies are similar to ASTH?
Notable peers in the same industry include GIB (CGI Inc.), BAH (Booz Allen Hamilton Holding Corporation), G (Genpact Limited), ASGN (ASGN Incorporated), RHI (Robert Half Inc.). Compare ASTH side-by-side with any of them on Quantisnow.How can I track ASTH on Quantisnow?
Quantisnow aggregates Astrana Health Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ASTH to receive live email and push alerts on every new disclosure.